{"company":{"id":3792695,"name":"Immunic Therapeutics","domain":"imux.com","url":"https://alion.io/company/imux"},"answer":"As of Nov 15, 2026, Alion lists 10 companies most like Immunic Therapeutics: DBV Technologies, Vera Therapeutics, SEISMIC TX, Zura Bio, Climb Bio, Spyre Therapeutics, Shattuck Labs, Dianthus Therapeutics, Nurix Therapeutics and Oruka Therapeutics.","highlights":["Immunic Therapeutics itself has 15 open roles on Alion.","Of them, Nurix Therapeutics is hiring the most, with 24 open roles.","Climb Bio has raised the most venture funding on record: $363.2M."],"as_of":"2026-11-15","cite":"Alion, \"Immunic Therapeutics competitors and alternatives: 10 similar companies compared on hiring and funding\", as of Nov 15, 2026. https://alion.io/company/imux/competitors","indexable":true,"target":{"name":"Immunic Therapeutics","url":"https://alion.io/company/imux","domain":"imux.com","open_roles":15,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":"venture","last_round_usd":null,"last_round_date":"2017-08-25","lead_investors":[]},"size_band":null,"headquarters":{"city":"Boston","country":"US"},"technologies":["CAPA","GMP","GCP"],"hiring_countries":["US","DE"],"similarity":null},"competitors":[{"name":"DBV Technologies","url":"https://alion.io/company/dbv-technologies","domain":"dbv-technologies.com","open_roles":16,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":null,"headquarters":{"city":"Washington","country":"US"},"technologies":["GCP","Python","Power BI"],"hiring_countries":["US","FR"],"similarity":{"score":14.45,"shared_segments":["Immunology & Inflammation Therapeutics"],"shared_technologies":["GCP","AI Agents","Microsoft Excel","GMP","Good Clinical Practice"],"same_hq_country":true}},{"name":"Vera Therapeutics","url":"https://alion.io/company/veratx","domain":"veratx.com","open_roles":10,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Brisbane","country":"US"},"technologies":["Microsoft Excel","CAPA","GCP"],"hiring_countries":["US"],"similarity":{"score":13.65,"shared_segments":["Immunology & Inflammation Therapeutics"],"shared_technologies":["GCP","Microsoft Excel","GMP","Good Clinical Practice","Veeva"],"same_hq_country":true}},{"name":"SEISMIC TX","url":"https://alion.io/company/seismictx","domain":"seismictx.com","open_roles":6,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"Watertown","country":"US"},"technologies":["Flow Cytometry","ELISA","Single-Cell Sequencing"],"hiring_countries":["US"],"similarity":{"score":12.45,"shared_segments":["Immunology & Inflammation Therapeutics"],"shared_technologies":["GCP","Microsoft Excel","Good Clinical Practice"],"same_hq_country":true}},{"name":"Zura Bio","url":"https://alion.io/company/zura-bio","domain":"zurabio.com","open_roles":4,"open_roles_change":null,"funding":{"total_raised_usd":128437485,"last_round":"venture","last_round_usd":112499985,"last_round_date":"2024-04-22","lead_investors":[]},"size_band":null,"headquarters":{"city":"Henderson","country":"US"},"technologies":["GCP","ICH Guidelines","Veeva"],"hiring_countries":["US"],"similarity":{"score":12.45,"shared_segments":["Immunology & Inflammation Therapeutics"],"shared_technologies":["GCP","ICH Guidelines","Veeva"],"same_hq_country":true}},{"name":"Climb Bio","url":"https://alion.io/company/climbbio","domain":"climbbio.com","open_roles":5,"open_roles_change":null,"funding":{"total_raised_usd":363245909,"last_round":"venture","last_round_usd":110076289,"last_round_date":"2026-04-29","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Boston","country":"US"},"technologies":["GCP","Power BI","CAPA"],"hiring_countries":["US"],"similarity":{"score":12.05,"shared_segments":["Immunology & Inflammation Therapeutics"],"shared_technologies":["GCP","CAPA"],"same_hq_country":true}},{"name":"Spyre Therapeutics","url":"https://alion.io/company/spyre","domain":"spyre.com","open_roles":3,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"11-50","headquarters":{"city":"Waltham","country":"US"},"technologies":["GCP","Microsoft Excel","Good Clinical Practice"],"hiring_countries":[],"similarity":{"score":11.95,"shared_segments":["Immunology & Inflammation Therapeutics"],"shared_technologies":["GCP","Microsoft Excel","Good Clinical Practice"],"same_hq_country":true}},{"name":"Shattuck Labs","url":"https://alion.io/company/world-3783078","domain":"shattucklabs.com","open_roles":1,"open_roles_change":null,"funding":{"total_raised_usd":154998876,"last_round":"venture","last_round_usd":83000009,"last_round_date":"2020-06-12","lead_investors":[]},"size_band":"201-500","headquarters":{"city":"Austin","country":"US"},"technologies":["GMP","Design of Experiments","JMP"],"hiring_countries":["US"],"similarity":{"score":11.65,"shared_segments":["Immunology & Inflammation Therapeutics"],"shared_technologies":["GMP"],"same_hq_country":true}},{"name":"Dianthus Therapeutics","url":"https://alion.io/company/dianthustherapeutics","domain":"dianthustherapeutics.com","open_roles":5,"open_roles_change":null,"funding":{"total_raised_usd":121507718,"last_round":"venture","last_round_usd":100000000,"last_round_date":"2022-04-06","lead_investors":[]},"size_band":"201-500","headquarters":{"city":"New York","country":"US"},"technologies":["R","MATLAB","ggplot2"],"hiring_countries":[],"similarity":{"score":11.55,"shared_segments":["Immunology & Inflammation Therapeutics"],"shared_technologies":["GCP","Microsoft Excel","GMP","Good Clinical Practice","ICH Guidelines"],"same_hq_country":true}},{"name":"Nurix Therapeutics","url":"https://alion.io/company/nurixtx","domain":"nurixtx.com","open_roles":24,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"San Francisco","country":"US"},"technologies":["GCP","Copilot","GMP"],"hiring_countries":["US"],"similarity":{"score":11.38,"shared_segments":["Immunology & Inflammation Therapeutics"],"shared_technologies":["GCP","Microsoft Excel","GMP","Good Clinical Practice","ICH Guidelines"],"same_hq_country":true}},{"name":"Oruka Therapeutics","url":"https://alion.io/company/oruka","domain":"oruka.com","open_roles":10,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Waltham","country":"US"},"technologies":["GCP","Good Clinical Practice","SAS"],"hiring_countries":["US"],"similarity":{"score":11.25,"shared_segments":["Immunology & Inflammation Therapeutics"],"shared_technologies":["GCP","GMP","Good Clinical Practice","Veeva","CAPA"],"same_hq_country":true}}],"method":"Ranked by Alion's similar-companies engine (the MCP tool similar_companies): shared industry segments and the overlap of the two segment sets, technologies named in both companies' job postings, the same headquarters country, a size band near it. Open roles are the visible postings on Alion today; their change is shown only for boards that state posting dates.","html_url":"https://alion.io/company/imux/competitors","json_url":"https://alion.io/company/imux/competitors.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","built_at":"2026-11-15T03:04:16Z","generated_at":"2026-11-16T00:10:19Z"}}